Despite overwhelming evidence for both tumor-suppressive and protumorigenic roles of the GRHL2 transcription factor in a large variety of human tumors, mechanisms modulating expression or activity of GRHL2 in cancer cells still are largely unknown. Here, GRHL2 is linked to neoplasm.